ENVIVO PHARMACEUTICALS
Similar Organizations
Bgm Pharmaceuticals
Bgm Pharmaceuticals is a privately owned Biotechnology company
Misfolding Diagnostics
Misfolding Diagnostics is a privately held biotech company.
Tagworks Pharmaceuticals
Tagworks Pharmaceuticals is a privately held biotech company
Current Employees Featured
More informations about "EnVivo Pharmaceuticals"
EnVivo Pharmaceuticals, Inc. Becomes FORUM ... - Fierce Biotech
WATERTOWN, Mass. – April 2, 2014 – EnVivo Pharmaceuticals, Inc. announced today that the company has changed its name to FORUM Pharmaceuticals Inc. The new name better …See details»
EnVivo Pharmaceuticals becomes FORUM Pharmaceuticals
Apr 3, 2014 EnVivo Pharmaceuticals has changed its name to FORUM Pharmaceuticals. The new name better reflects the company’s strong position as a late-stage, purpose-built …See details»
EnVivo Pharmaceuticals, Inc. Becomes FORUM ... - Business Wire
Apr 2, 2014 EnVivo Pharmaceuticals, Inc. announced today that the company has changed its name to FORUM Pharmaceuticals Inc. ... purpose-built organization that is focused on …See details»
EnVivo Pharmaceuticals, Inc. Becomes FORUM Pharmaceuticals
Apr 2, 2014 WATERTOWN, Mass.--(BUSINESS WIRE)--EnVivo Pharmaceuticals, Inc. announced today that the company has changed its name to FORUM Pharmaceuticals Inc. …See details»
Watertown biotech EnVivo changes name to Forum …
The new name for the biotech formerly known as EnVivo Pharmaceuticals, and headed by former Millennium CEO Deborah Dunsire, is meant to reflect "the company's strong position as a late …See details»
Ex-Millennium: The Takeda Oncology Company CEO to Head …
Jul 11, 2013 EnVivo Pharmaceuticals, Inc., based in Watertown, Mass., is a privately held company working to convert its broad pipeline into a range of CNS therapies that leverage …See details»
EnVivo Pharmaceuticals Announces Appointment of President and …
Jul 12, 2013 EnVivo Pharmaceuticals announced the appointment of Deborah Dunsire, M.D., as president and chief executive officer. She also joins the company’s board of directors. Dr. ...See details»
EnVivo Pharmaceuticals - Crunchbase Company Profile & Funding
Organization. EnVivo Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Alternatives and possible competitors to EnVivo …See details»
Deborah Dunsire - President and Chief Executive …
Jan 20, 2015 Primary Organization . EnVivo Pharmaceuticals . Gender Female; ... Dr. Dunsire has served as President and Chief Executive Officer of EnVivo Pharmaceuticals since July 2013. Before joining EnVivo, she served as …See details»
EnVivo Pharmaceuticals, Inc - VentureRadar
Similar Companies: Neurophth China Privately Held Neurophth is a Chinese biotech developing gene therapeutics for ophthalmological diseases. Neurophth was founded by Prof Bin Li's …See details»
Dunsire's new biotech, Envivo, takes on Alzheimer's in late-stage …
EnVivo Pharmaceuticals, a privately-held biotech headed by former Millennium Pharmaceuticals CEO Deborah Dunsire, has begun a late-stage trial involving 1,600 patients of a potential drug …See details»
Ex-Millennium: The Takeda Oncology Company CEO to Head …
Jul 12, 2013 EnVivo Pharmaceuticals Announces Appointment of Deborah Dunsire, M.D., as President and Chief Executive Officer WATERTOWN, Mass.--(BUSINESS WIRE)-- EnVivo …See details»
EnVivo Pharmaceuticals Announces Statistically Significant …
Jul 19, 2012 About EVP-6124 EnVivo Pharmaceuticals' lead compound, EVP-6124, is a selective, potent, brain penetrant, oral alpha-7 nicotinic agonist being developed as a long …See details»
EnVivo Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks
Organization. EnVivo Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. IT Spend by Aberdeen. Edit IT Spend by Aberdeen …See details»
EnVivo Announces Positive Phase 2b Clinical Data in …
May 17, 2011 WATERTOWN, Mass.--(BUSINESS WIRE)-- EnVivo Pharmaceuticals announced today positive topline results of its randomized, placebo-controlled Phase 2b clinical trial of …See details»
EnVivo Pharmaceuticals - Contacts, Employees, Board Members, …
EnVivo Pharmaceuticals has 1 current employee profile, President and Chief Executive Officer Deborah Dunsire. Deborah Dunsire President and Chief Executive Officer Unlock even more …See details»
EnVivo starts Phase III study of encenicline for treatment of …
Jan 24, 2014 EnVivo Pharmaceuticals has started COGNITIV AD, a Phase III clinical trial evaluating its new alpha-7 (a7) potentiator, encenicline-hydrochloride (EVP-6124), in patients …See details»
Fidelity invests $65 in EnVivo Pharma, takes over
Oct 31, 2008 Neurological-drug developer EnVivo Pharmaceuticals received $65 million in a series D round closed in April, bringing EnVivo's total venture financing to nearly $125 million. …See details»
EnVivo Enters Phase 2b Trials for Its EVP-6124 Compound in the ...
Jan 5, 2010 EnVivo Pharmaceuticals, located in Watertown, Mass., is a biopharmaceutical company dedicated to discovering and developing small molecule therapeutics for disorders of …See details»
EnVivo Pharmaceuticals Presents Additional EVP-6124 Phase 2b …
Nov 1, 2012 EnVivo Pharmaceuticals’ lead compound, EVP-6124, is a selective, potent, brain penetrant, oral alpha-7 nicotinic agonist being developed as a long-term treatment to restore …See details»